Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Server chassis
Electronic device, information processing method, and storage medium
Packet transmission method, apparatus, and network system
Storage apparatus and method including page discard processing for primary and secondary volumes configured as a copy pair
Method and apparatus for a cryptographically assisted commercial network system designed to facilitate buyer-driven conditional purchase offers
Round carrying case
  Randomly Featured Patents
Mobile ad hoc network (MANET) providing connectivity enhancement features and related methods
Interlocking knife edge seals
Automatic crossbar on ski chair-lift for facilitating passenger dismount
Computer/keyboard built into refrigerator door
Pipe bursting and replacement apparatus
Marshaling and un-marshaling data types in XML and Java
Method for protecting human skin from ultraviolet radiation
Sense amplifier circuit
Compositions and methods for hydroxylating epothilones
Outerwear garment article